CURIS INC

Nasdaq: CRISGrowth candidate

58 days public · Biological Products, (No Diagnostic Substances) · $0.67 (-5.38%)

Growth candidate RANKED

/ 100 fit

Confidence100%

Curis Inc (CRIS) has been evaluated for the Growth investment strategy, achieving a deterministic fit score of 76 out of 100 based on recent fundamentals, institutional ownership, and reporting narrative.

Intelligence score

/ 100 core

Suggested alloc

30%

cap · your limits

Days public

EARLY PUBLIC

Last price

$0.67

live quote

1d change

-5.38%

session

Why selectedLIVE

EQUENCY Reasoning Engine

+Institutional ownership is strong with 6 Schedule 13D/13G disclosures on file with the SEC, contributing a sub-score of 100.
+Narrative momentum is supported by 8 Form 8-K filings and 14 insider forms submitted to the SEC, yielding a sub-score of 100.
+Fundamentals reflect reported revenue, cash reserves, and positive equity on the balance sheet, resulting in a sub-score of 66 despite a net loss.

RisksLIVE